Xyratex Misses Q3 Estimates and 4 Stock Analyses Buzzing Today
Xyratex Ltd. (NASDAQ:XRTX): Following their missed third quarter results, Brean Murray lowered their price target on Xyratex Ltd. The firm cited lowered company guidance, a decrease in demand across the customer base, as well as delays in customer acceptance and revenue recognition. Shares remain Buy rated.
Wet Seal Inc. (NASDAQ:WTSLA): Following better than expected September comps, Brean Murray said that Wet Seal Inc. remains a solid turn around play. The firm cited their rich balance sheet and the catalysts from a new management or a potential takeout. Shares are Buy rated with a $4.00 price target.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
VeriSign Inc. (NASDAQ:VRSN): Cowen said that Verisign Inc. deserves its rich premium given their monopoly of .com/net, their significant pricing and margin leverage, as well as potential for an improved capital structure. The firm trimmed their near term estimates on subdued domain activity but said they will remain a top name for the next 12 months. Shares are Outperform rated.
FEI Co. (NASDAQ:FEIC): After FEI Co.’s stock declined by 5%, Stifel Nicolaus continues to expect the company’s revenues and earnings to increase for the second half of 2012 as compared to the first half of the year. The firm believes that during the second half of 2012 and into 2013, FEI’s bookings will be boosted by a number of positive catalysts. They maintain a $60 target and Buy rating on their shares.
Heartware International Inc. (NASDAQ:HTWR): ThinkEquity expects that revenue from HeartWare International Inc.’s fourth quarter United States HeartWare Ventricular Assist System (HVAD) will come in below expectations and they anticipate that the company could report “a series of disappointing quarters over the next 6-12 months.” The firm believes that the stock carries significant risk at current levels and they maintain a Sell rating on their shares.